KASINGER JAMES R. (General Counsel and Secretary) sold 2.1% of their position (1.99K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $119.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/8/2026ACC: 0001193125-26-418101
Officer· General Counsel and Secretary
Since Feb 2026
-1.99K
Net shares
Net seller
$119.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.99K acquired · 3.98K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+1.99K
Price / share
$13.62
Trade value
$27.10K
% of position
2.1%
10/6/2026
94.78K→96.77K
Common Shares
Direct
Shares
−1.99K
Price / share
$60.04
Trade value
$119.48K
% of position
2.1%
10/6/2026
96.77K→94.78K
Total
Net shares
+0.00
Net value
-$92.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 10/6/2026 | M · Option Exercise | +1.99K | $13.62 | $27.10K | 2.1% | 94.78K | 96.77K |
| Common Shares Direct | 10/6/2026 | S · Sale | −1.99K | $60.04 | $119.48K | 2.1% | 96.77K | 94.78K |
| Total | +0.00 | -$92.38K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
1.99K shares
Shares
−1.99K
Strike price
13.62
Held after
81.24K
Exercisable
—
10/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares1.99K shares | 10/6/2026 | M · Option Exercise | −1.99K | 13.62 | — | 81.24K |